ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3063

Ocular Findings and Ocular Blood Flow Changes in Takayasu Arteritis: A Subclinical Reduction in Blood Flow with a Milder Clinical Course of Retinopathy

Ali Ugur Unal1, Fehim Esen2, Fatma Alibaz-Oner3, Gulce Celik4, Haluk Kazokoglu5 and Haner Direskeneli1, 1Department of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey, 2Department of Ophthalmology, Marmara University Faculty of Medicine, Istanbul, Turkey, 3Department Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey, 4Department of Internal Medicine, Marmara University Faculty of Medicine, Istanbul, Turkey, 5Department of Ophtalmalogy, Marmara University Faculty of Medicine, Istanbul, Turkey

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Doppler ultrasound, ocular involvement and takayasu arteritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Vasculitis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Ocular involvement in Takayasu arteritis (TAK) mainly arises due to complications related with altered ocular blood flow or side effects of the treatments. In this study, we aimed to document ocular complication rates, ocular blood flow status and the association of ocular blood flow parameters with clinical outcome of the Takayasu arteritis patients followed in a tertiary rheumatology clinic.

Methods: We have included 65 Takayasu arteritis patients followed at Marmara University Medical School, Rheumatology Division (F/M:60/5 , mean age: 41.8 ±12.9 years) and 51 healthy subjects (F/M: 50/1, mean age: 37.4 ±12.9 years) in this study. All of the participants had a detailed ophthalmological examination with optical coherence tomography scan of the macula, retinal nerve fiber layer and choroid. Ocular blood flow in ophthalmic and central retinal arteries was evaluated with Color Doppler ultrasonography. The rheumatology examination data was provided from the last rheumatology visit at which the patients were referred to the ophthalmology clinic.

Results: The most common ocular complication was hypertensive retinopathy (33.9%). Only 4 patients had retinal findings related with Takayasu retinopathy (6.2%). Thirteen eyes had posterior subcapsular cataract (10%) and 7 eyes were pseudophacic (5.4%). None of the patients suffered from a reduction of visual acuity due to ischemic neovascular complications. There was no statistically significant difference between the TAK patients and healthy subjects for the central macular thickness, foveal volume, retinal nerve fiber layer thickness and subfoveal choroideal thickness. TAK patients had an increase of resistivity index in the ophthalmic artery (0.75 vs. 0.66, p=0.002) and central retinal artery (0.75 vs. 0.67, p=0.001). Patients with hypertensive retinopathy had a significantly longer disease duration compared to the group with no retinopathy (7.9 years vs. 4.7 years, p=0.016), while there was no statistically significant difference between the groups for upper extremity blood pressure values. The resistivity index of the ophthalmic artery was higher in patients with ipsilateral radial artery pulselessness compared to the patients who had no pulselessness (0.77 vs. 0.68, p=0.031). The patients with carotid artery bruits did not have a significant change in the ocular blood flow parameters compared to the patients without carotid artery bruits. There was also no significant difference for ocular blood flow parameters between the patients with long  (>5 years) or short disease duration (<5 years).

Conclusion: The prevalence of Takayasu arteritis was lower in our study compared to previous series. However, while none of the patients complained about visual disturbances, Doppler findings indicate a subclinical reduction in ocular blood flow in these patients.

 


Disclosure: A. U. Unal, None; F. Esen, None; F. Alibaz-Oner, None; G. Celik, None; H. Kazokoglu, None; H. Direskeneli, None.

To cite this abstract in AMA style:

Unal AU, Esen F, Alibaz-Oner F, Celik G, Kazokoglu H, Direskeneli H. Ocular Findings and Ocular Blood Flow Changes in Takayasu Arteritis: A Subclinical Reduction in Blood Flow with a Milder Clinical Course of Retinopathy [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/ocular-findings-and-ocular-blood-flow-changes-in-takayasu-arteritis-a-subclinical-reduction-in-blood-flow-with-a-milder-clinical-course-of-retinopathy/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ocular-findings-and-ocular-blood-flow-changes-in-takayasu-arteritis-a-subclinical-reduction-in-blood-flow-with-a-milder-clinical-course-of-retinopathy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology